These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 2402122

  • 1. Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure.
    Conte G, Dal Canton A, Imperatore P, De Nicola L, Gigliotti G, Pisanti N, Memoli B, Fuiano G, Esposito C, Andreucci VE.
    Kidney Int; 1990 Aug; 38(2):301-7. PubMed ID: 2402122
    [Abstract] [Full Text] [Related]

  • 2. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
    Kim HJ.
    Nephron; 1996 Aug; 72(3):476-82. PubMed ID: 8852501
    [Abstract] [Full Text] [Related]

  • 3. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.
    Blumberg A, Weidmann P, Shaw S, Gnädinger M.
    Am J Med; 1988 Oct; 85(4):507-12. PubMed ID: 3052050
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
    Montoliu J, Lens XM, Revert L.
    Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia.
    Salem MM, Rosa RM, Batlle DC.
    Am J Kidney Dis; 1991 Oct; 18(4):421-40. PubMed ID: 1928061
    [Abstract] [Full Text] [Related]

  • 9. Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end-stage renal disease.
    Gutierrez R, Schlessinger F, Oster JR, Rietberg B, Perez GO.
    Miner Electrolyte Metab; 1991 Oct; 17(5):297-302. PubMed ID: 1668124
    [Abstract] [Full Text] [Related]

  • 10. Adrenergic modulation of extrarenal potassium disposal.
    Rosa RM, Silva P, Young JB, Landsberg L, Brown RS, Rowe JW, Epstein FH.
    N Engl J Med; 1980 Feb 21; 302(8):431-4. PubMed ID: 6101508
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
    Nahum H, Paillard M, Prigent A, Leviel F, Bichara M, Gardin JP, Idatte JM.
    Am J Nephrol; 1986 Feb 21; 6(4):253-62. PubMed ID: 3777034
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Determinants of plasma potassium levels in diabetic ketoacidosis.
    Adrogué HJ, Lederer ED, Suki WN, Eknoyan G.
    Medicine (Baltimore); 1986 May 21; 65(3):163-72. PubMed ID: 3084904
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients.
    Mahajan SK, Mangla M, Kishore K.
    J Assoc Physicians India; 2001 Nov 21; 49():1082-5. PubMed ID: 11868861
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.